-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on IDEAYA Biosciences, Lowers Price Target to $48

Benzinga·07/07/2026 16:15:18
Listen to the news
RBC Capital analyst Leonid Timashev maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and lowers the price target from $53 to $48.